Ameriprise
RNAC icon

Ameriprise’s Cartesian Therapeutics RNAC Stock Holding History

Ameriprise’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,416
Closed -$82.5K – 4230
2026
Q1 		$82.5K Sell
13,416
-6,390
-32% -$45.5K ﹤0.01% 3977
2025
Q4 		$143K Buy
+19,806
New +$160K ﹤0.01% 3968
2024
Q1 		– Sell
-11,716
Closed -$242K – 3943
2023
Q4 		$242K Sell
11,716
-1,782
-13% -$53.2K ﹤0.01% 3671
2023
Q3 		$429K Sell
13,498
-120
-0.9% -$4.01K ﹤0.01% 3467
2023
Q2 		$458K Buy
13,618
+657
+5% +$23.5K ﹤0.01% 3473
2023
Q1 		$540K Buy
12,961
+3,673
+40% +$173K ﹤0.01% 3402
2022
Q4 		$316K Sell
9,288
-182
-2% -$7.74K ﹤0.01% 3567
2022
Q3 		$466K Sell
9,470
-290
-3% -$15.9K ﹤0.01% 3419
2022
Q2 		$383K Sell
9,760
-4,038
-29% -$120K ﹤0.01% 3484
2022
Q1 		$509K Buy
13,798
+4,101
+42% +$257K ﹤0.01% 3481
2021
Q4 		$949K Buy
+9,697
New +$1.04M ﹤0.01% 3283
2021
Q3 		– Sell
-1,372
Closed -$172K – 3943
2021
Q2 		$172K Sell
1,372
-1,511
-52% -$180K ﹤0.01% 3776
2021
Q1 		$391K Sell
2,883
-143
-5% -$17.8K ﹤0.01% 3491
2020
Q4 		$275K Buy
3,026
+1,559
+106% +$135K ﹤0.01% 3526
2020
Q3 		$109K Sell
1,467
-133
-8% -$10.2K ﹤0.01% 3633
2020
Q2 		$136K Buy
+1,600
New +$145K ﹤0.01% 3554
2018
Q4 		– Sell
-4,502
Closed -$2.1M – 3752
2018
Q3 		$2.1M Buy
4,502
+1,722
+62% +$692K ﹤0.01% 2800
2018
Q2 		$1.1M Buy
+2,780
New +$986K ﹤0.01% 2979

Other funds holding RNAC

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ameriprise's RNAC Position: Q2 2026 in Review

Ameriprise sold out of Cartesian Therapeutics (RNAC) in Q2 2026, closing a stake of 13,416 shares — an estimated $82.5K sold.

Ameriprise first reported a position in RNAC in Q2 2018 and held it in 18 quarters. The position peaked at $2.1M in Q3 2018. 95 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Ameriprise reported no remaining Cartesian Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 13,416 Cartesian Therapeutics shares in Q2 2026, an estimated $82.5K.
  • Ameriprise first reported a position in Cartesian Therapeutics in Q2 2018 and held it in 18 quarters.
  • Ameriprise's Cartesian Therapeutics position peaked at $2.1M in Q3 2018.
  • 95 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.